Personal tools

DOID:9119: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
{{DOID
{{DOID
|id=DOID:9119
|alt_id=DOID:9118;;DOID:9171
|name=acute myeloid leukemia
|namespace=disease_ontology
|def=
|xref=ICD9CM:205.0;;MSH:D015470;;NCI:C27753;;NCI:C3171;;OMIM:601626;;SNOMEDCT_2010_1_31:154591002;;SNOMEDCT_2010_1_31:17788007;;SNOMEDCT_2010_1_31:277600006;;SNOMEDCT_2010_1_31:413443009;;SNOMEDCT_2010_1_31:91861009;;UMLS_CUI:C0023467
|is_a=DOID:8692
|synonym="acute myeloblastic leukemia (disorder)" EXACT [SNOMEDCT_2005_07_31:277600006];;"acute myeloid leukaemia" EXACT [SNOMEDCT_2005_07_31:154591002];;"acute myeloid leukaemia, disease" EXACT [SNOMEDCT_2005_07_31:91861009];;"acute myeloid leukemia without mention of remission" EXACT [];;"AML" EXACT [CSP2005:4000-0108];;"AML - acute Myeloid Leukemia" EXACT [NCI2004_11_17:C3171];;"ANLL in Remission" EXACT [NCI2004_11_17:C3588];;"Leukemia, Myelocytic, acute" EXACT [MTH:NOCODE]
|comment=OMIM mapping confirmed by DO. [SN].
|comment=OMIM mapping confirmed by DO. [SN].
|alt_id=DOID:9118;;DOID:9171
|disjoint_from=
|union_of=
|created_by=
|created_by=
|obo_creation_date=
|def=
|subset=
|derives_from=
|derives_from=
|develops_from=
|develops_from=
|disjoint_from=
|has_quality=
|has_quality=
|id=DOID:9119
|is_a=DOID:8692
|is_obsolete=
|located_in=
|located_in=
|name=acute myeloid leukemia
|namespace=FANTOM
|obo_creation_date=
|part_of=
|part_of=
|preceded_by=
|property_value=IAO:0000412 file:/Users/cjm/Dropbox/fantom5/HumanDO.obo
|property_value=IAO:0000412 file:/Users/cjm/Dropbox/fantom5/HumanDO.obo
|is_obsolete=
|subset=
|preceded_by=
|synonym="acute myeloblastic leukemia (disorder)" EXACT [SNOMEDCT_2005_07_31:277600006];;"acute myeloid leukaemia" EXACT [SNOMEDCT_2005_07_31:154591002];;"acute myeloid leukaemia, disease" EXACT [SNOMEDCT_2005_07_31:91861009];;"acute myeloid leukemia without mention of remission" EXACT [];;"AML" EXACT [CSP2005:4000-0108];;"AML - acute Myeloid Leukemia" EXACT [NCI2004_11_17:C3171];;"ANLL in Remission" EXACT [NCI2004_11_17:C3588];;"Leukemia, Myelocytic, acute" EXACT [MTH:NOCODE]
|union_of=
|xref=ICD9CM:205.0;;MSH:D015470;;NCI:C27753;;NCI:C3171;;OMIM:601626;;SNOMEDCT_2010_1_31:154591002;;SNOMEDCT_2010_1_31:17788007;;SNOMEDCT_2010_1_31:277600006;;SNOMEDCT_2010_1_31:413443009;;SNOMEDCT_2010_1_31:91861009;;UMLS_CUI:C0023467
}}
}}

Latest revision as of 16:52, 12 September 2014

Name:acute myeloid leukemia
Namespace:FANTOM
Xrefs:
links:

ICD9CM:205.0
MSH:D015470
NCI:C27753
NCI:C3171
OMIM:601626
SNOMEDCT_2010_1_31:154591002
SNOMEDCT_2010_1_31:17788007
SNOMEDCT_2010_1_31:277600006
SNOMEDCT_2010_1_31:413443009
SNOMEDCT_2010_1_31:91861009

UMLS_CUI:C0023467
Synonyms: "acute myeloblastic leukemia (disorder)" EXACT [SNOMEDCT_2005_07_31:277600006]
"acute myeloid leukaemia" EXACT [SNOMEDCT_2005_07_31:154591002]
"acute myeloid leukaemia, disease" EXACT [SNOMEDCT_2005_07_31:91861009]
"acute myeloid leukemia without mention of remission" EXACT []
"AML" EXACT [CSP2005:4000-0108]
"AML - acute Myeloid Leukemia" EXACT [NCI2004_11_17:C3171]
"ANLL in Remission" EXACT [NCI2004_11_17:C3588]
"Leukemia, Myelocytic, acute" EXACT [MTH:NOCODE]
Comments:OMIM mapping confirmed by DO. [SN].
Alt_id: DOID:9118
DOID:9171

Ontology association<br>Each term has an is_a parent in the Disease Ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to DISEASE ontologies.<br><br>link to ontology dataset<br>data

Parents

is_a:DOID:8692(myeloid leukemia)



Children


is a:FF:10699-109G6 (acute myeloid leukemia (FAB M7) cell line:M-MOK)

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)

FF samples

Human (Homo sapiens)

  • 10699-109G6 (acute myeloid leukemia (FAB M7) cell line:M-MOK)

Mouse (Mus musculus)

  • 10699-109G6 (acute myeloid leukemia (FAB M7) cell line:M-MOK)

Enrichment analysis: top 100 FFCP enriched with this ontology termTOP 100 FANTOM5 Cage Peaks enriched with DOID:9119 (acute myeloid leukemia), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data

P-valueFFCPShort description
5.42e-195FFCP PHASE1:Hg19::chrX:15589921..15589927,-#_b345d985d6ea331d91d68332803817e7p@chrX:15589921..15589927, -
5.42e-195FFCP PHASE1:Hg19::chr2:98375925..98375935,-#_b345d985d6ea331d91d68332803817e7p17@TMEM131
5.42e-195FFCP PHASE1:Hg19::chr12:11949422..11949423,-#_b345d985d6ea331d91d68332803817e7p@chr12:11949422..11949423, -
5.42e-195FFCP PHASE2:Hg19::chr8:62597251..62597256,-#_b345d985d6ea331d91d68332803817e7p29@ASPH
5.42e-195FFCP PHASE2:Hg19::chr12:11949422..11949423,-#_b345d985d6ea331d91d68332803817e7p@chr12:11949422..11949423, -
5.42e-195FFCP PHASE1:Hg19::chr8:62597251..62597256,-#_b345d985d6ea331d91d68332803817e7p29@ASPH
5.42e-195FFCP PHASE2:Hg19::chr5:178996248..178996252,+#_b345d985d6ea331d91d68332803817e7p@chr5:178996248..178996252, +
5.42e-195FFCP PHASE2:Hg19::chrX:15589921..15589927,-#_b345d985d6ea331d91d68332803817e7p@chrX:15589921..15589927, -
5.42e-195FFCP PHASE1:Hg19::chr5:178996248..178996252,+#_b345d985d6ea331d91d68332803817e7p@chr5:178996248..178996252, +
5.42e-195FFCP PHASE2:Hg19::chr2:98375925..98375935,-#_b345d985d6ea331d91d68332803817e7p17@TMEM131
9.37e-99FFCP PHASE2:Hg19::chr8:62597218..62597226,-#_4d2b4a0ed41b9091ad5fc8272bb5d439p27@ASPH
9.37e-99FFCP PHASE2:Hg19::chr5:178996286..178996298,+#_4d2b4a0ed41b9091ad5fc8272bb5d439p@chr5:178996286..178996298, +
9.37e-99FFCP PHASE2:Hg19::chr22:30138461..30138492,-#_4d2b4a0ed41b9091ad5fc8272bb5d439p@chr22:30138461..30138492, -
9.37e-99FFCP PHASE1:Hg19::chr8:62597218..62597226,-#_4d2b4a0ed41b9091ad5fc8272bb5d439p27@ASPH
9.37e-99FFCP PHASE1:Hg19::chr5:178996286..178996298,+#_4d2b4a0ed41b9091ad5fc8272bb5d439p@chr5:178996286..178996298, +
9.37e-99FFCP PHASE2:Hg19::chr5:178996302..178996310,+#_4d2b4a0ed41b9091ad5fc8272bb5d439p@chr5:178996302..178996310, +
9.37e-99FFCP PHASE1:Hg19::chr22:30138461..30138492,-#_4d2b4a0ed41b9091ad5fc8272bb5d439p@chr22:30138461..30138492, -
9.37e-99FFCP PHASE1:Hg19::chr5:178996302..178996310,+#_4d2b4a0ed41b9091ad5fc8272bb5d439p@chr5:178996302..178996310, +
9.37e-99FFCP PHASE2:Hg19::chr19:14590350..14590358,-#_4d2b4a0ed41b9091ad5fc8272bb5d439p@chr19:14590350..14590358, -
9.37e-99FFCP PHASE2:Hg19::chr9:22922267..22922278,-#_4d2b4a0ed41b9091ad5fc8272bb5d439p@chr9:22922267..22922278, -
9.37e-99FFCP PHASE1:Hg19::chr19:14590350..14590358,-#_4d2b4a0ed41b9091ad5fc8272bb5d439p@chr19:14590350..14590358, -
9.37e-99FFCP PHASE1:Hg19::chr9:22922267..22922278,-#_4d2b4a0ed41b9091ad5fc8272bb5d439p@chr9:22922267..22922278, -
2.55e-98FFCP PHASE2:Hg19::chr7:73752953..73752964,+#_c8f3ac45657cf0e1b3e89c45fb9bc4b4p@chr7:73752953..73752964, +
2.55e-98FFCP PHASE2:Hg19::chr3:194899235..194899237,+#_c8f3ac45657cf0e1b3e89c45fb9bc4b4p@chr3:194899235..194899237, +
2.55e-98FFCP PHASE2:Hg19::chr10:11894144..11894162,+#_c8f3ac45657cf0e1b3e89c45fb9bc4b4p@chr10:11894144..11894162, +
2.55e-98FFCP PHASE1:Hg19::chr10:11894144..11894162,+#_c8f3ac45657cf0e1b3e89c45fb9bc4b4p@chr10:11894144..11894162, +
2.55e-98FFCP PHASE1:Hg19::chr3:194899235..194899237,+#_c8f3ac45657cf0e1b3e89c45fb9bc4b4p@chr3:194899235..194899237, +
2.55e-98FFCP PHASE1:Hg19::chr7:73752953..73752964,+#_c8f3ac45657cf0e1b3e89c45fb9bc4b4p@chr7:73752953..73752964, +
2.55e-98FFCP PHASE1:Hg19::chr12:131856861..131856875,+#_c8f3ac45657cf0e1b3e89c45fb9bc4b4p@chr12:131856861..131856875, +
2.55e-98FFCP PHASE2:Hg19::chr12:131856861..131856875,+#_c8f3ac45657cf0e1b3e89c45fb9bc4b4p@chr12:131856861..131856875, +
1.23e-66FFCP PHASE2:Hg19::chr10:73830227..73830232,-#_ecfe6531962b659c522353930a3e0d61p26@SPOCK2
1.23e-66FFCP PHASE1:Hg19::chr12:10016587..10016603,-#_ecfe6531962b659c522353930a3e0d61p@chr12:10016587..10016603, -
1.23e-66FFCP PHASE2:Hg19::chr12:10016587..10016603,-#_ecfe6531962b659c522353930a3e0d61p@chr12:10016587..10016603, -
1.23e-66FFCP PHASE2:Hg19::chr5:178996177..178996199,+#_ecfe6531962b659c522353930a3e0d61p@chr5:178996177..178996199, +
1.23e-66FFCP PHASE1:Hg19::chr12:11949500..11949512,-#_ecfe6531962b659c522353930a3e0d61p@chr12:11949500..11949512, -
1.23e-66FFCP PHASE2:Hg19::chr12:11949500..11949512,-#_ecfe6531962b659c522353930a3e0d61p@chr12:11949500..11949512, -
1.23e-66FFCP PHASE1:Hg19::chr10:63524522..63524527,-#_ecfe6531962b659c522353930a3e0d61p@chr10:63524522..63524527, -
1.23e-66FFCP PHASE2:Hg19::chr10:63524522..63524527,-#_ecfe6531962b659c522353930a3e0d61p@chr10:63524522..63524527, -
1.23e-66FFCP PHASE1:Hg19::chr5:178996177..178996199,+#_ecfe6531962b659c522353930a3e0d61p@chr5:178996177..178996199, +
1.23e-66FFCP PHASE1:Hg19::chr10:73830227..73830232,-#_ecfe6531962b659c522353930a3e0d61p26@SPOCK2
2.39e-66FFCP PHASE2:Hg19::chr7:73752919..73752928,+#_f8f89f6bd439404fa0b8c30e26b28ca9p@chr7:73752919..73752928, +
2.39e-66FFCP PHASE1:Hg19::chr7:73752919..73752928,+#_f8f89f6bd439404fa0b8c30e26b28ca9p@chr7:73752919..73752928, +
2.39e-66FFCP PHASE2:Hg19::chr5:75922796..75922808,+#_f8f89f6bd439404fa0b8c30e26b28ca9p@chr5:75922796..75922808, +
2.39e-66FFCP PHASE2:Hg19::chr19:1842983..1842999,-#_f8f89f6bd439404fa0b8c30e26b28ca9p@chr19:1842983..1842999, -
2.39e-66FFCP PHASE1:Hg19::chr5:75922796..75922808,+#_f8f89f6bd439404fa0b8c30e26b28ca9p@chr5:75922796..75922808, +
2.39e-66FFCP PHASE1:Hg19::chr19:1842983..1842999,-#_f8f89f6bd439404fa0b8c30e26b28ca9p@chr19:1842983..1842999, -
2.39e-66FFCP PHASE2:Hg19::chrX:155227410..155227421,+#_f8f89f6bd439404fa0b8c30e26b28ca9p4@IL9R
2.39e-66FFCP PHASE2:Hg19::chr7:1275077..1275088,+#_f8f89f6bd439404fa0b8c30e26b28ca9p@chr7:1275077..1275088, +
2.39e-66FFCP PHASE2:Hg19::chr18:45479920..45479950,-#_f8f89f6bd439404fa0b8c30e26b28ca9p@chr18:45479920..45479950, -
2.39e-66FFCP PHASE1:Hg19::chr12:4501908..4501927,+#_f8f89f6bd439404fa0b8c30e26b28ca9p@chr12:4501908..4501927, +
2.39e-66FFCP PHASE2:Hg19::chr12:4501908..4501927,+#_f8f89f6bd439404fa0b8c30e26b28ca9p@chr12:4501908..4501927, +
2.39e-66FFCP PHASE1:Hg19::chrX:155227410..155227421,+#_f8f89f6bd439404fa0b8c30e26b28ca9p4@IL9R
2.39e-66FFCP PHASE1:Hg19::chr7:1275077..1275088,+#_f8f89f6bd439404fa0b8c30e26b28ca9p@chr7:1275077..1275088, +
2.39e-66FFCP PHASE1:Hg19::chr18:45479920..45479950,-#_f8f89f6bd439404fa0b8c30e26b28ca9p@chr18:45479920..45479950, -
2.39e-66FFCP PHASE1:Hg19::chr12:4524557..4524579,+#_f8f89f6bd439404fa0b8c30e26b28ca9p@chr12:4524557..4524579, +
2.39e-66FFCP PHASE2:Hg19::chr12:4524557..4524579,+#_f8f89f6bd439404fa0b8c30e26b28ca9p@chr12:4524557..4524579, +
4.66e-66FFCP PHASE1:Hg19::chr5:65998399..65998404,+#_a4127c8d208da887f95882901aee6eb0p@chr5:65998399..65998404, +
4.66e-66FFCP PHASE2:Hg19::chr5:65998373..65998383,+#_a4127c8d208da887f95882901aee6eb0p@chr5:65998373..65998383, +
4.66e-66FFCP PHASE1:Hg19::chr5:65998373..65998383,+#_a4127c8d208da887f95882901aee6eb0p@chr5:65998373..65998383, +
4.66e-66FFCP PHASE2:Hg19::chr5:65998399..65998404,+#_a4127c8d208da887f95882901aee6eb0p@chr5:65998399..65998404, +
2.42e-50FFCP PHASE1:Hg19::chr16:3647506..3647511,-#_c643eab415fef847ecfba79a5f3c3812p@chr16:3647506..3647511, -
2.42e-50FFCP PHASE1:Hg19::chr4:69048379..69048399,-#_c643eab415fef847ecfba79a5f3c3812p@chr4:69048379..69048399, -
2.42e-50FFCP PHASE2:Hg19::chr10:49667817..49667824,-#_c643eab415fef847ecfba79a5f3c3812p@chr10:49667817..49667824, -
2.42e-50FFCP PHASE1:Hg19::chr10:49667817..49667824,-#_c643eab415fef847ecfba79a5f3c3812p@chr10:49667817..49667824, -
2.42e-50FFCP PHASE2:Hg19::chr10:49667833..49667844,-#_c643eab415fef847ecfba79a5f3c3812p@chr10:49667833..49667844, -
2.42e-50FFCP PHASE1:Hg19::chr10:49667833..49667844,-#_c643eab415fef847ecfba79a5f3c3812p@chr10:49667833..49667844, -
2.42e-50FFCP PHASE2:Hg19::chr4:69048379..69048399,-#_c643eab415fef847ecfba79a5f3c3812p@chr4:69048379..69048399, -
2.42e-50FFCP PHASE2:Hg19::chr16:3647506..3647511,-#_c643eab415fef847ecfba79a5f3c3812p@chr16:3647506..3647511, -
3.99e-50FFCP PHASE1:Hg19::chr11:36119758..36119765,+#_85ca947bf12da14001935a2b83289aedp9@LDLRAD3
3.99e-50FFCP PHASE2:Hg19::chr11:36119758..36119765,+#_85ca947bf12da14001935a2b83289aedp9@LDLRAD3
3.99e-50FFCP PHASE1:Hg19::chr15:71506595..71506599,+#_85ca947bf12da14001935a2b83289aedp@chr15:71506595..71506599, +
3.99e-50FFCP PHASE2:Hg19::chr15:71506595..71506599,+#_85ca947bf12da14001935a2b83289aedp@chr15:71506595..71506599, +
3.99e-50FFCP PHASE2:Hg19::chr6:26500524..26500540,+#_85ca947bf12da14001935a2b83289aedp@chr6:26500524..26500540, +
3.99e-50FFCP PHASE1:Hg19::chr11:36119908..36119916,+#_85ca947bf12da14001935a2b83289aedp7@LDLRAD3
3.99e-50FFCP PHASE2:Hg19::chr11:36119908..36119916,+#_85ca947bf12da14001935a2b83289aedp7@LDLRAD3
3.99e-50FFCP PHASE1:Hg19::chr6:26500524..26500540,+#_85ca947bf12da14001935a2b83289aedp@chr6:26500524..26500540, +
6.58e-50FFCP PHASE2:Hg19::chr19:35485484..35485496,+#_e7302fa7bae70aae05213660af2c37d0p16@GRAMD1A
6.58e-50FFCP PHASE1:Hg19::chr21:16125761..16125771,-#_e7302fa7bae70aae05213660af2c37d0p4@ENST00000454128
6.58e-50FFCP PHASE1:Hg19::chr19:35485484..35485496,+#_e7302fa7bae70aae05213660af2c37d0p16@GRAMD1A
6.58e-50FFCP PHASE2:Hg19::chr1:164409412..164409413,-#_e7302fa7bae70aae05213660af2c37d0p@chr1:164409412..164409413, -
6.58e-50FFCP PHASE2:Hg19::chr10:135379108..135379119,-#_e7302fa7bae70aae05213660af2c37d0p3@SYCE1
6.58e-50FFCP PHASE1:Hg19::chr1:164409412..164409413,-#_e7302fa7bae70aae05213660af2c37d0p@chr1:164409412..164409413, -
6.58e-50FFCP PHASE1:Hg19::chr10:135379108..135379119,-#_e7302fa7bae70aae05213660af2c37d0p3@SYCE1
6.58e-50FFCP PHASE2:Hg19::chr17:41006104..41006119,+#_e7302fa7bae70aae05213660af2c37d0p4@AOC3
6.58e-50FFCP PHASE2:Hg19::chr21:16125761..16125771,-#_e7302fa7bae70aae05213660af2c37d0p4@ENST00000454128
6.58e-50FFCP PHASE1:Hg19::chr17:41006104..41006119,+#_e7302fa7bae70aae05213660af2c37d0p4@AOC3
6.62e-41FFCP PHASE2:Hg19::chr11:64569296..64569303,-#_d068327ecc1d350ec0983c3635ff2a4dp9@MAP4K2
6.62e-41FFCP PHASE2:Hg19::chr19:55671313..55671321,-#_d068327ecc1d350ec0983c3635ff2a4dp@chr19:55671313..55671321, -
6.62e-41FFCP PHASE2:Hg19::chr2:197674076..197674085,-#_d068327ecc1d350ec0983c3635ff2a4dp@chr2:197674076..197674085, -
6.62e-41FFCP PHASE1:Hg19::chrX:155227315..155227335,+#_d068327ecc1d350ec0983c3635ff2a4dp3@IL9R
6.62e-41FFCP PHASE1:Hg19::chr19:55671313..55671321,-#_d068327ecc1d350ec0983c3635ff2a4dp@chr19:55671313..55671321, -
6.62e-41FFCP PHASE1:Hg19::chr2:197674076..197674085,-#_d068327ecc1d350ec0983c3635ff2a4dp@chr2:197674076..197674085, -
6.62e-41FFCP PHASE1:Hg19::chr11:36119770..36119780,+#_d068327ecc1d350ec0983c3635ff2a4dp8@LDLRAD3
6.62e-41FFCP PHASE2:Hg19::chr11:36119770..36119780,+#_d068327ecc1d350ec0983c3635ff2a4dp8@LDLRAD3
6.62e-41FFCP PHASE2:Hg19::chr3:196230198..196230216,-#_d068327ecc1d350ec0983c3635ff2a4dp9@RNF168
6.62e-41FFCP PHASE2:Hg19::chr20:9147236..9147246,+#_d068327ecc1d350ec0983c3635ff2a4dp20@PLCB4
6.62e-41FFCP PHASE1:Hg19::chr3:196230198..196230216,-#_d068327ecc1d350ec0983c3635ff2a4dp9@RNF168
6.62e-41FFCP PHASE1:Hg19::chr20:9147236..9147246,+#_d068327ecc1d350ec0983c3635ff2a4dp20@PLCB4
6.62e-41FFCP PHASE2:Hg19::chrX:155227315..155227335,+#_d068327ecc1d350ec0983c3635ff2a4dp3@IL9R
6.62e-41FFCP PHASE1:Hg19::chr11:64569296..64569303,-#_d068327ecc1d350ec0983c3635ff2a4dp9@MAP4K2

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=DOID:9119&oldid=3275741"